Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β₃-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB).
about
Mirabegron in overactive bladder patients: efficacy review and update on drug safetyBK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function.Profile of mirabegron in the treatment of overactive bladder: place in therapy.A drug safety evaluation of mirabegron in the management of overactive bladder.The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality.Incontinence: The dilemma with comparing efficacy of OAB treatments.Comprehensive review of cardiovascular toxicity of drugs and related agents.Recent advances in pharmacological management of urinary incontinence.P2X2 and P2X5 Receptors Mediate Bladder Hyperesthesia in ICC in Female Overactive Bladder.
P2860
Q28072230-3211F9F3-9748-49E8-A20E-3E5E283DD909Q37211818-2C8F5B41-1E79-463E-9B8A-8DF687593E6CQ37664787-6942525A-C4F9-44B0-BDCA-27677780E3CEQ38776115-78777337-BA75-4ADF-8A79-4C2EB800C527Q39406932-EBB12D19-CA42-4080-AC5F-761AD11BC578Q47321030-03DFCA15-F7ED-405C-8169-404E003680A2Q47556269-D1D30C6D-30DE-4ED1-AF77-85C1901CFF00Q48247040-B9E64B5B-4651-4E21-BA8F-3D72550543D0Q50595581-9920428E-473E-4034-91B2-20ACBB6A4593
P2860
Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β₃-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Critical analysis of phase II ...... for overactive bladder (OAB).
@en
type
label
Critical analysis of phase II ...... for overactive bladder (OAB).
@en
prefLabel
Critical analysis of phase II ...... for overactive bladder (OAB).
@en
P2093
P2860
P356
P1433
P1476
Critical analysis of phase II ...... ) for overactive bladder (OAB)
@en
P2093
Alessandro Iannetti
Giacomo Novara
Marta Rossanese
Vincenzo Ficarra
P2860
P356
10.1111/BJU.12730
P577
2014-07-27T00:00:00Z